Dr. Gary Ghiselli, who helped host Murphy Huston’s wife with a back degeneration and the show’s producer Graig Weisbart, guest starred on No Copay Radio April 16th.
Dr. Gary Ghiselli shares information about:
I am pleased to announce that I will be returning to Colorado Spine Partners in October. I value the support and understanding that I have received during my absence and want to thank everyone for their patience during this time.
After a lot of thought I have come to the decision that upon my return, I will be restructuring my practice. I have decided to shift the focus of my practice to specializing in the treatment of the cervical spine. The treatment of cervical spine ailments has always been my passion and I feel that this is where my attention should be focused. I will be scheduling new and established patients that require evaluations and surgical consultations for their cervical spine issues beginning October 9, 2017.
With regard to my prior patients that were being treated for their lumbar spine, I realize this change may be difficult and I hope to make this transition in care as smooth as possible for you.
Dr. Ghiselli recently published a paper based on work he did with the University of Denver assessing lumbar spine intervertebral kinematics of people who do and do not develop standing-induced low back pain. (Kinematics - geometrically possible motion of a body or system of bodies without consideration of the forces involved.)
Dr. Ghiselli’s study set out to evaluate the safety and efficacy of a single injection of mesenchymal precursor cells (MPCs, or stem cells) combined with hyaluronic acid. Study subjects had chronic low back pain associated with degenerative disc disease, and were followed for 36 months after their injection.
Results showed that injection of MPCs could be a safe, effective, durable and minimally invasive therapy for subjects who have chronic low back pain.
Colorado Spine Partners announced that it has enrolled its first patient in a nationwide FDA- cleared adult stem cell study testing novel treatment for chronic low back pain. The study will test the use of Mesenchymal Precursor Cells (MPCs) – adult stem cells derived from bone marrow that will be directly injected into the lumbar disc. The minimally invasive procedure may offer an alternative to back surgery for eligible patients with chronic pain from degenerative discs.
Click here to read more about this Research Study.
Gary Ghiselli, MD, a board-certified spine surgeon, is a board member of the Colorado Orthopedic Society. He researches problems in the cervical, thoracic and lumbar spine. Dr. Ghiselli also serves as a Guideline Committee Member for the NASS, is a member of AAOS and the Colorado Medical Society.
Dr. Ghiselli focuses on anti-microbial substrates, stem cell and regenerative technologies in his research. He is a member of the Cervical Spine Research Society and investigates FDA trials dealing with motion preservation in the lumbar spine, cervical total disc replacement and stem cell applications.
He graduated from University of Texas, Southwestern Medical School in Dallas and completed an internship at UCLA General Surgery in Los Angeles. Dr. Ghiselli did his fellowship in spinal surgery with a focus on cervical spine disorders and trauma at the University Hospital of Cleveland under Henry H. Bohlman, MD. Please click here to learn more.
Here are are 60 spine surgeons who are participating in clinical trials or have a research focus on biologics and/or stem cells for spine surgery. Dr. Ghiselli was the principal investigator in the FDA-cleared adult stem cell study testing the novel treatment for chronic low back pain, which began in early 2012. The study used mesenchymal precursor cells to be injected directly into the lumbar disc. Please click here to learn more.
Techniques and procedures for minimally invasive surgery of the spine have developed considerably in recent decades and have since become more popular among spine surgeons, in some cases even more so than the traditional open approaches, according to sources who spoke with Spine Surgery Today.
Gary Ghiselli, MD, said he finds minimally invasive surgery (MIS) of the spine more cost-effective than open surgery. It does more to address the quality of life for patients during the immediate recovery period, “as well as the long-term viability of the muscles and tissues overlying the spine,” he said.
The Executive Editorial Board of The Spine Journal selected Incidence of contraindications to total disc arthroplasty: a retrospective review of 100 consecutive fusion patients with a specific analysis of facet arthrosis written by David A. Wong, MD, MSc, FRCS(C), Sanjay Jatana, MD, Gary Ghiselli, MD of Colorado Spine Partners as the winner of the first annual TSJ Editors' Choice Award. Click here to download a PDF of the article selected as the top paper among those published in The Spine Journal for volume year 2007 (new window will open).
1529-9430/06/$ – see front matter © 2007 Elsevier Inc. All rights reserved. doi:10.1016/j.spinee.2006.04.012